Interventional Radiology Market By Product Type (MRI Systems, CT Scanners, Ultrasound Imaging Systems, Angiography Systems, Others), By Procedure (Angioplasty, Biopsy, Embolization {Peripheral Embolization, Prostatic Artery Embolization, Genicular Artery Embolization, Fibroid, Others}, Thrombolysis, Vertebroplasty, Nephrostomy, Interventional Oncology, MSK Intervention, Others), By Application (Cardiology, Oncology, Urology, Gastroenterology, Obstetrics, Gynecology, Others), By Treatment Method (Vascular Interventions, Tumor Ablation, Drainage Procedures, Biopsy Procedures, Fistula Creation, Others) and By End-user (Hospitals, Clinics, Ambulatory Surgical Centres, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Interventional Radiology market accounted for USD 29.1 Billion in 2024 and is expected to reach USD 60.0 Billion by 2035, growing at a CAGR of around 6.8% between 2025 and 2035. The market of interventional radiology is based on minimally invasive procedures with the guidance of imaging technologies for the diagnosis and treatment of various types of medical conditions. This specialty is a combination of elements of both radiology and surgery, minimizing risks and time required to come back for recovery, as well as other complications that always accompany traditional surgeries. Main procedures include angioplasty and embolization, biopsies, and thrombolysis, and are applied in cardiology, oncology, urology, gastroenterology. These factors include the growing incidence of chronic diseases, technological advancement in imaging technology, and increased preference for outpatient care that makes interventional radiology an integral part of modern healthcare.

Report Scope:

Market Dynamics

Innovations in Imaging Technologies Improve Procedural Accuracy and Safety

The Interventional Radiology market is significantly driven by progressions in imaging innovations such as MRI, CT scans, and ultrasound, which improve procedural accuracy and persistent security. These innovations give high-resolution images and real-time visualization, empowering interventional radiologists to analyze and treat conditions with more prominent accuracy. For instance, MRI allows for detailed imaging of delicate tissues, whereas CT scans are basic for visualizing complex vascular structures during intercessions like stent situations and biopsies. This innovative advancement improves strategies in general victory rates and minimizes related risks.

With around 17.9 million deaths attributed to cardiovascular diseases globally, as famous by the World Health Organization (WHO), advanced imaging innovations are crucial for improving patient results. Real-time guidance during procedures can reduce complications by up to 50%, according to studies distributed within the Journal of the American College of Radiology. Improved imaging techniques have shown a 30-40% improvement in clinical outcomes, as stated by the Radiological Society of North America (RSNA). Additionally, patients experiencing minimally invasive methods frequently experience recovery times that are 30-50% shorter than those of conventional surgeries, according to the National Institutes of Health (NIH). The significance of exact diagnostic and interventional techniques is more critical than ever.

Growing Preference for Minimally Invasive Procedures

Interventional radiology is witnessing increasing demand for the minimally invasive treatment. It is in high demand because these treatments take fewer recovery periods, amount to less pain, and show lesser scarring than does traditional surgery. Such techniques reduce postoperative pain by 30%, as reported by the American College of Surgeons, and even shorter hospital stays by 1 to 2 days, according to the NIH.

In addition to making these procedures more accessible, the technologies have also made them safer and more effective and thus more acceptable to patients. 90% of patients are satisfied with minimally invasive treatment, and herein lies a large portion of its popularity say, the Society of Interventional Radiology. Shorter recoveries continue to make economic sense for healthcare providers and insurers.

High Cost of Equipment and Procedure

High cost of equipment and procedures is the principal challenges of the Interventional Radiology market. The modern imaging machines such as MRI and CT scanner with a cost between $150,000 and $3 million also incur huge investments for hospitals. Maintenance and operational costs consume more funds, and hence it is not possible for hospitals, especially in developing regions, to adopt these technologies.

Procedures are costly due to high-value materials required for stents, catheters, and highly trained professionals. All these contribute to higher costs of treatment, which makes Interventional Radiology inaccessible to many patients who cannot afford full insurance coverage. Declining reimbursement rates also make health care facilities incur losses, and therefore, the investment in this technology in underserved areas is limited.

Growth Potential from Increasing Outpatient Procedure Adoption

The trend towards outpatient procedures is concerned, significant growth opportunity does exist for the health sector. Outpatient procedures are relatively less expensive as compared with inpatient care, which can save up to 50% in costs, therefore significantly appealing to patients and insurance companies alike. Further, outpatient care is much more convenient; patients recover quickly, and there is also a reduced risk of hospital-acquired infections, since nearly 1 in 25 patients that enter the hospital acquire such an infection.

Technological advances in the field of minimally invasive techniques have made so many procedures possible to be done as an outpatient, often with an equal or even better outcome than an equivalent inpatient surgery. Government policies are increasingly on the side of outpatient care; wider coverage as demonstrated through the Ambulatory Surgical Center (ASC) payment system. A critical shift in the process of designing, communicating, and delivering evidence-based care is likely to help providers efficiently bridge the gap and provide quality healthcare closer to home, thus transforming health outcomes. By exploiting these changes, healthcare service organizations can better serve themselves to improvement and well-position for sustained growth.

Enhancing Patient Access Through Telemedicine in Interventional Radiology

Telemedicine is unlocking a wide range of opportunities for interventional radiologists as a means of providing better access to care and simplification of caring for patients, particularly in underserved and rural areas. The new ability to connect with patients remotely to have consultations and follow-ups can reduce certain travel barriers to help ensure that more patients obtain expert care without having to take long trips to health facilities, as emphasized in the U.S. More than 60 million people in Health and Human Services live in what are termed as Health Professional Shortage Areas, thereby clearly indicating a need for services in better access towards specialized departments.

Additionally, the study was conducted by the Journal of the American College of Radiology, according to which telehealth consultations for interventional procedures increase patient satisfaction and reduce wait times for appointments. Seventy-four percent of patients would be interested in using telemedicine, so this represents a very high demand to have access through remote care options," the American Medical Association reports. Better integration into their practice will improve access and convenience for patients while enhancing care coordination, thus leading to better health outcomes and increased efficiency in patient management.

Industry Experts Opinion

“IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”

• Chris Landon, Business Leader Image Guided Therapy Procedures at Philips

“Improvements in outcomes following peripheral vascular intervention have lagged compared to other endovascular treatments, such as percutaneous coronary intervention,”

-Eric A. Secemsky, MD Internal Medicine-Interventional Cardiology, Interventional Cardiology

Segment Analysis

Based on the product type, The interventional radiology market is segmented as MRI Systems, CT Scanners, Ultrasound Imaging Systems, Angiography Systems, and Others. Each type is a necessary component of the minimally invasive procedure-s: MRI Systems offer imaging of soft tissue in detail, CT scanners help for cross-sectional views in the shortest time period possible, Ultrasound Imaging Systems help for the guidance in real-time, and Angiography Systems can be helpful for the viewing blood vessels in relation to interventions. Others include specialized imaging technologies to augment the quality of interventional radiology practices.

Based on procedure, the interventional radiology market can be segmented into procedures such as Angioplasty, Biopsy, Embolization, Peripheral Embolization, Prostatic Artery Embolization, Genicular Artery Embolization, Fibroid Embolization, Thrombolysis, Vertebroplasty, Nephrostomy, Interventional Oncology, Musculoskeletal (MSK) Intervention, and Others. It is indispensable that each of these medical procedures caters to specific human health needs: enhancing the diameter of blood vessels, sampling tissue, and destroying tumor cells, among others. Others include further specialized applications beyond those mentioned above, therefore going wide in scope in the use of interventional radiology.

Regional Analysis

North America is a significant interventional radiology market because the healthcare system is well-advanced, and chronic diseases, including cardiovascular diseases and cancer, are highly prevalent. According to the Centers for Disease Control and Prevention, heart disease has been the leading cause of deaths in the United States. This factor requires interventions such as an angioplasty. The American College of Radiology noted a very high growth rate in interventional procedures over the last decade; this is largely due to the preference shown by patients towards minimally invasive treatments. Technological advancements along with supportive regulatory and reimbursement policies, provide an added impetus in favor of innovative imaging modalities like MRI and CT. Research and development are also continually being invested in; this places the North American interventional radiology market well for further growth, while aiming to enhance patient outcomes and increase the scope of applications of procedural techniques.  

The Asia-Pacific region is rapidly emerging as a key player in the interventional radiology market, largely driven by huge investments made in the healthcare sector, coupled with the increasing prevalence of chronic diseases. Due to greater awareness of treatment options, countries like China, India, and Japan are now witnessing an unprecedented demand for minimally invasive procedures. An expanding health care infrastructure in the region is due to advanced hospitals and specialty clinics, which support the use of state-of-the-art image guidance technologies like MRI, CT, and ultrasound systems. Government initiatives with respect to strengthening health care access and affordability augment the growth of interventional radiology. A huge patient population along with increased disposable incomes accelerates expansion of market. Additionally, the Asia-Pacific region is improving procedural outcomes through advancements in medical technology as well as in training programs for health care professionals. This brings interventional radiology more centrally positioned within modern healthcare systems throughout the Asia-Pacific region.

Competitive Landscape

The interventional radiology market is dominated by several major players, such as GE Healthcare, Fujifilm Corporation, Canon Medical Systems, and Agfa-Gevaert Group. These companies focus on the advancement of imaging technologies and therefore on enhancing procedural outcomes with innovations. The company, for instance, has recently launched AI-powered imaging solutions to improve diagnostic accuracy for GE Healthcare, while Fujifilm's product portfolio in ultrasound systems has been enhanced.

 Furthermore, Carestream Health has solidified its edge by acquiring new imaging technologies, therefore expanding the portfolio for interventional radiology. Esaote SPA continues the saga of innovation with special MRI and ultrasound systems tailored for minimally invasive procedures. Overall, strategic mergers, acquisitions, and partnerships among these players are driving growth and competition in the market, while paving the way to developing innovative solutions in interventional radiology.

Interventional Radiology Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In June 2024, GE HealthCare and MediView XR Inc. have announced the inaugural installation of the OmnifyXR interventional suite at North Star Vascular and Interventional (NSVI) in Minneapolis, Minnesota. This launch represents a significant enhancement of GE HealthCare’s interventional radiology portfolio and is anticipated to expand their customer reach in the market.
• In June 2024, Royal Philips has announced the first implantation of the Duo Venous Stent System, designed to address symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), following its premarket approval (PMA) from the U.S. Food and Drug Administration (FDA). This milestone is expected to enhance the company’s market reputation and solidify its position within the industry.

Report Coverage:

By Product Type

• MRI Systems
• CT Scanners
• Ultrasound Imaging Systems
• Angiography Systems
• Others

By Procedure

• By Procedure:
• Angioplasty
• Biopsy
• Embolization
  • Peripheral Embolization
  • Prostatic Artery Embolization
  • Genicular Artery Embolization
  • Fibroid
  • Others
• Thrombolysis
• Vertebroplasty
• Nephrostomy
• Interventional Oncology
• MSK Intervention
• Others

By Application

• Cardiology
• Oncology
• Urology
• Gastroenterology
• Obstetrics
• Gynecology
• Others

By Treatment Method

• Vascular Interventions
• Tumor Ablation
• Drainage Procedures
• Biopsy Procedures
• Fistula Creation
• Others

By End-user

• Hospitals
• Clinics
• Ambulatory Surgical Centres
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Agfa-Gevaert Group
• Canon Medical Systems Corporation
• Carestream Health Inc.
• Cook
• Esaote SPA
• Fujifilm Corporation
• GE Healthcare
• Hologic, Inc.
• Koninklijke Philips N. V
• Olympus Corporation
• Samsung Healthcare (Samsung Electronics Co., Ltd.)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Shimadzu Corporation
• Siemens Healthineers
• Teleflex Incorporated

Frequently Asked Questions (FAQs)